Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ketofol is a pharmacological combination consisting of ketamine and propofol, typically mixed in a single syringe or infusion bag for intravenous administration. It is widely used for procedural sedation and the induction or maintenance of general anesthesia. The rationale behind the combination is to achieve a synergistic sedative and analgesic effect while mitigating the adverse hemodynamic and respiratory profiles of the individual components; ketamine's sympathomimetic properties help counteract propofol-induced hypotension, while propofol may reduce the incidence of ketamine-associated emergence delirium and vomiting. Recent clinical research, such as studies conducted by Cairo University, has explored its potential neuroprotective role in preventing postoperative delirium in high-risk elderly populations undergoing major oncological surgeries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ketamine + propofol.